FDA Priority Review Voucher Redemption Fee Set At $4.6 Million In Fiscal 2011
Users of the voucher, designed as an incentive for developing therapies for tropical diseases, will pay the fee on top of the standard $1.5 million PDUFA user fee.
Users of the voucher, designed as an incentive for developing therapies for tropical diseases, will pay the fee on top of the standard $1.5 million PDUFA user fee.